HCPCS code J2001 – Lidocaine HCl intravenous infusion

Key takeaways

J2001 was deleted on October 1, 2024, and the last valid date of service was September 30, 2024.

J2003 is the main replacement for plain lidocaine HCl, with J2002 for lidocaine in 5% dextrose and J2004 for lidocaine with epinephrine.

The replacement codes are billed per 1 mg, so a 200 mg dose is now 200 units rather than 20.

Most payers still expect an NDC and a separate administration CPT code, such as 96365 or 96374, on lidocaine drug claims.

J2001 now belongs only on corrections, appeals, and audits for dates of service on or before September 30, 2024.

HCPCS Code J2001: Definition and code status

HCPCS Code J2001 was the billing code for injection, lidocaine HCl for intravenous infusion, 10 mg. CMS deleted it effective October 1, 2024, so the last valid date of service was September 30, 2024.

There was no grace period. From October 1, 2024, lidocaine is billed with one of three new codes, each counted per 1 mg. J2003 covers lidocaine hydrochloride and replaces most former J2001 use. J2002 covers lidocaine in 5% dextrose, and J2004 covers lidocaine with epinephrine.

Like the codes that replaced it, J2001 was an HCPCS Level II drug code maintained by CMS, not a CPT code from the AMA. It reported the drug supply only. The infusion service was always billed separately with a CPT administration code.

J2001 code details at a glance

Use this reference when you correct an older claim or update a charge master that still lists J2001.

Is HCPCS Code J2001 still active in 2026?

No. HCPCS Code J2001 has not been valid since October 1, 2024, and CMS has not reinstated it. The October 2024 quarterly HCPCS update deleted it, and Medicare contractors confirmed the change in their bulletins. These include CGS and Noridian’s October 2024 HCPCS update.

AAPC Codify lists J2001 as a deleted code, effective October 1, 2024. Any claim with J2001 on a date of service after September 30, 2024 is rejected as an invalid code. Commercial payers whose edits follow the CMS HCPCS Level II code files reject it as well.

Those rejections usually trace back to stale system data. A charge master, an order set, or an infusion template that still maps lidocaine to J2001 keeps producing denials until someone updates it.

Replacement codes: What to bill instead of J2001

CMS replaced J2001 with three lidocaine codes on October 1, 2024. Each one is defined by the product rather than the route, and each is billed per 1 mg. CMS published no single formal crosswalk, so the product you used decides the code.

The diagram below walks through both decisions, date of service first and then the product.

The NDC crosswalk from the Pricing, Data Analysis and Coding (PDAC) contractor, dated October 5, 2024, moved most former J2001 NDCs to J2003. Use it to check each product you stock.

1. Identify the product. Read the NDC on the vial or bag that was given, not the one on the order.
2. Match the NDC to a code. Look it up in the current PDAC NDC–HCPCS crosswalk to confirm J2002, J2003, or J2004.
3. Recalculate the units. Count 1 unit per mg given, as covered in the units section below.
4. Confirm with your MAC. Check your Medicare contractor’s October 2024 HCPCS bulletin if a product does not appear in the crosswalk.

What IV lidocaine is used for and where it is billed

IV lidocaine is given for indications such as ventricular arrhythmia and infusion-based pain management, including post-surgical pain protocols. Coverage for any one indication is set by the payer. For Medicare, that means National or Local Coverage Determinations.

Practices billing IV lidocaine for chronic pain should confirm which LCD applies with their Medicare Administrative Contractor (MAC) before submitting.

Eligible Part B settings include hospital outpatient departments (HOPDs), physician offices, ambulatory surgery centers (ASCs), and infusion centers. HOPD claims are paid under the Hospital Outpatient Prospective Payment System (OPPS). Physician office claims are paid under the Medicare Physician Fee Schedule and the quarterly drug pricing files.

• Separately reportable: lidocaine given as a drug in its own right, such as an IV infusion, coded J2002 or J2003.
• Usually bundled: lidocaine used as local anesthesia for a procedure, which Medicare generally treats as part of that procedure’s payment.
• Not covered by these codes: topical and oral lidocaine products, which have their own coding rules.

How to calculate units for the lidocaine replacement codes

J2002, J2003, and J2004 are billed at 1 unit per 1 mg, so the unit count equals the milligrams given. J2001 counted 10 mg per unit. A J2001 multiplier carried into the new codes under-reports every claim tenfold.

Bill the milligrams given, taken from the infusion record. If the physician orders 200 mg but the infusion stops at 180 mg, report 180 units of J2003. Always check the nursing infusion log against the order before you count units.

Medicare’s JW and JZ modifier policy applies to drugs from single-dose containers. Report any discarded amount on its own line with JW, or add JZ when none was discarded. Multi-dose vials are outside that policy.

NDC reporting requirements for lidocaine claims

Most Medicare MACs and many commercial payers expect a National Drug Code (NDC) alongside the HCPCS drug code. A missing or invalid NDC is a fast route to a rejection. Getting it right is part of clean claim submission, and it matters more now that the NDC decides which replacement code applies.

Report the NDC as an 11-digit number in the 5-4-2 labeler-product-package format. On the CMS-1500 and the 837P, it goes on the drug line after the N4 qualifier. The unit qualifier and the quantity follow it.

• Qualifier: N4, the NDC qualifier on the 837P and the CMS-1500.
• Format: 11 digits in 5-4-2 segments, with no hyphens in the electronic field.
• Unit qualifier: UN (units), ML (milliliters), or GR (grams), matched to the drug’s labeled unit of measure.
• Quantity: the amount of product dispensed, which is not the same figure as the HCPCS billing units.

CGS (Jurisdiction 15) and Noridian (Jurisdictions E and F) both enforce NDC reporting on Part B drug claims. Record the NDC from the vial or bag used. A transcription error between the label and the claim line is a common audit finding.

Which administration CPT codes pair with lidocaine drug codes

The HCPCS lidocaine codes report the drug only. The administration is billed separately with a CPT code from the therapeutic infusion and injection series. A drug line without an administration code, or with the wrong administration type, is a common reason for denial.

CPT treats an infusion of 15 minutes or less as a push, so it is reported with 96374 rather than 96365. Choose the administration code from the documented start and stop times, so the drug line and the service line tell the same story. The same CPT pairing rules applied to J2001 claims.

Medicare coverage and reimbursement for lidocaine

Medicare Part B covers IV lidocaine when it is medically necessary and the record supports the indication. In the physician office, separately payable Part B drugs are generally paid from the Average Sales Price (ASP) files. The usual rate is ASP plus 6%.

CMS updates those files every quarter, so a dollar figure in a reference guide goes stale quickly. Check the current quarter’s ASP pricing file for J2002, J2003, or J2004. You can also use the CMS Physician Fee Schedule lookup.

Payment in the hospital outpatient setting follows the OPPS, which packages many low-cost drugs into the related service. Confirm with your HOPD billing team whether the lidocaine line is separately paid or packaged for your claim. Pabau’s claims software for billers tracks drug-code payments by payer, so underpayments surface quickly.

When J3490 applies to lidocaine

J3490 is the unclassified injectable drug code, used only when no specific J-code describes the drug. With J2002, J2003, and J2004 in place, almost every lidocaine product now has a specific code. J3490 is rarely correct for lidocaine.

The main exception is a compounded lidocaine preparation that none of the three descriptors fits. Some payers also give their own instructions for products missing from the PDAC crosswalk. An unclassified claim triggers manual review, so attach the drug invoice, the NDC, and a statement of medical necessity.

Documentation requirements to support lidocaine drug claims

Inadequate documentation drives most post-payment takebacks on drug claims. The record must support the drug, the route, the dose, the indication, and the setting. Each element maps to a field on the claim. Good superbill documentation captures them at the point of care.

• Physician order: states the IV route, the dose in milligrams, and the frequency. A verbal order recorded later without a countersignature is a common audit target.
• Infusion nursing log: records start and stop times, total volume, rate, and any dose changes. Both the unit count and the administration code come from this log.
• ICD-10-CM diagnosis: links the documented indication to the lidocaine order, such as an arrhythmia, a pain diagnosis, or a post-surgical indication.
• Drug label details: the NDC and lot number of the vial or bag used. They decide the replacement code and give you an audit trail.
• Medical necessity note: a brief clinical statement of why IV lidocaine was needed, for Medicare and payers that require prior authorization.

Build these checkpoints into the clinical workflow itself. Billing staff should not have to reconstruct them after the patient has left.

Common denial reasons for lidocaine claims and how to avoid them

Lidocaine denials follow recognizable patterns, and the code change added two new ones. Strong denial management workflows and medical billing compliance processes keep most of them from reaching the payer.

How Pabau supports lidocaine and other drug-code billing

Practices that bill infused drugs carry a quarterly risk. CMS can delete or split a J-code at any HCPCS update. A single missed change can produce weeks of denied claims before anyone spots the pattern.

Pabau holds claims for review before they go out. Billing staff see the HCPCS code, the unit count, and the linked diagnoses on one screen while the claim is still editable. A J2001 line or a 10 mg unit multiplier gets caught there instead of at the payer.

Infusion notes, consent forms, and authorization details sit on the patient’s record. The NDC and the start and stop times are on hand when the claim is built. Denials that do land are grouped by reason code. A wave of invalid-code rejections becomes visible within days instead of at month end.

Catch deleted drug codes before claims go out

Pabau holds claims for review with the HCPCS code, units, and linked diagnoses on one screen. Denials are grouped by reason code, so a quarterly code change does not turn into weeks of rework.

Book a demo

Conclusion

J2001 is gone, but stale system data can keep it on claims. Start with any charge master or order set still carrying J2001 or a 10 mg multiplier. Then map each lidocaine NDC you stock to J2002, J2003, or J2004.

The lesson applies well beyond lidocaine. When CMS splits a drug code, both the code and the unit size change, and either one alone can sink a claim. Book a demo to see how Pabau helps you catch drug-code changes before they reach your denial queue.

Continue your research

Want to understand how the 837P electronic claim is structured? 837 file billing guide explains how drug codes, NDC qualifiers, and diagnosis codes fit together in an electronic claim submission.

Billing a short lidocaine push rather than an infusion? CPT code 96374 covers IV push billing, modifiers, and the documentation that separates a push from an infusion.

Frequently asked questions